INTRODUCTION
Patients with symptoms of low back pain report a substantial improvement in pain and function with either surgical or conservative treatment. 1 Sciatica, however, is an important factor of worse prognosis in such cases, 2 because it generates higher fi nancial cost, in addition to greater disability for work and absenteeism at work. 3 Sciatica can be defi ned as neuropathic pain originating from injury to the nervous system, caused by compression, diabetes mellitus, infection, trauma, and autoimmune diseases. 4 For some authors, the term refers only to radiculopathies. However, sciatica is widely known as the pain arising from the lower back, or along the nerve trajectory, and radiating down to the leg. 5 It is associated with paresthesia and possible neurological defi cit, such as paresis and refl ex alterations. The major cause of symptoms is an infl ammatory reaction that results in nerve irritation or compression. The prevalence of symptoms varies in the literature from 1.6% to 46%, and that can be explained by differences in the defi nitions used, data collection methods, and populations studied. Disc herniation and lumbar or foraminal stenoses are typical diseases that cause sciatica; however, there are several other reasons, such as extraspinal tumors and cysts. 3 Awkward posture, exposure to whole body vibration, and long periods in a seated position have also been related to a higher risk for developing sciatica.
Treatments vary. Medicamentous therapy, although being the most commonly used treatment, has adverse side effects that jeopardize the risk/benefi t ratio. 7 Nonsurgical interventional therapies also exist, but few of them have shown to be effective. 8 In the short run, the surgical treatment is the most effective, but, on the long run, its benefi ts decrease. 9 Finally, there is the conservative, nonpharmacological treatment, which includes physical therapy modalities, whose risks are rare and evidence of effi cacy is still insuffi cient. 10 Thus, studies on the physical therapy modalities for the treatment of sciatica are necessary. The use of experimental animals has shown to be useful for the pre-clinical assessment of the nociception caused by nerve injuries, 11 such as the nerve compression model reported by Bennett and Xie, 12 which simulates sciatica fi ndings.
One of the electrostimulation modalities used in clinical practice is high-voltage current. According to Davini et al., 13 there is evidence that such therapy decreases pain and improves tissue repair. The high-voltage current can be described as pulsed, monophasic, double peak, high voltage (over 100 V), with pulse duration of 5-100 μs and high peak amplitude. Such characteristics provide a relatively pleasant stimulation, capable of reaching not only sensory and motor nerve fibers, but also those responsible for conducting nociceptive impulses. The high-voltage current finds application especially in cases of cutaneous ulcers and edema reduction, mainly with cathodic stimulation. Thus, the present study aimed at assessing, by using cathodic high-voltage current, the increase in nociception due to experimental sciatica.
MATERIALS AND METHODS

Experimental groups
This study assessed 16 male Wistar rats (Rattus norvegicus), whose mean weight was 376.80 ± 24.68 g, and mean age, 14 ± 2 weeks. The animals were maintained in polypropylene cages, submitted to light/dark cycles of 12 hours and temperature of 25 ± 1 ºC, and had free access to water and food during the entire experiment.
The animals were randomly divided into two groups: Sham group (GS, n = 8): submitted to sciatica in the right hind paw and placebo treatment;
Group treated with cathodic current (GP-, n = 8): submitted to sciatica and treated with cathodic current in the surgical site.
The project was conducted according to the international guidelines of ethics in animal experimentation and approved by the Animal Experimentation Ethics Committee (protocol #0209) of the Universidade Estadual do Oeste do Paraná (Unioeste). Table 1 shows the time sequence of the study. 
Experimental injury protocol
The animals were anesthetized with intraperitoneal xylazine (12 mg/kg) and ketamine (95 mg/kg), and, then, epilation was performed on the surgical site. An incision parallel to the fi bers of the biceps femoris muscle of the right thigh was performed, thus exposing the sciatic nerve. In accordance with the model described by Bennett and Xie, 12 compression around the nerve was performed in four distinct points, with an approximate distance of 1 mm between them, by using chromic catgut 4.0, reproducing the symptoms of sciatica. Then, suture in layers was performed.
Functional disability test
The animals underwent the functional disability test, originally described by Tonussi and Ferreira.
14 Their nociception was assessed while they walked over a cylinder of 30-cm diameter, covered with a stainless steel net and rotating at 3 rpm, powered by an electric engine. The hind paws received metallic boots. The right boot conducted information from the right hind paw to a computer. The computer ran a program that measured the time during which the boot did not contact the cylinder while the animal walked over the cylinder for one minute. Thus, the time (in seconds) during which the right hind paw contacted the cylinder and the time during which the animal held its hind paw in a guarded position (THHP) could be measured. The boot remained on the left hind paw, but provided no input to the computer, so that both limbs experienced the same sensations. Tonussi and Ferreira 14 have reported that, while walking over the cylinder for one minute, animals with no alterations usually hold their hind paw in a guarded position for approximately 10 seconds.
The experiment began after the third day of training, which consisted in walking over the cylinder. Data collection was initiated before surgery (fi rst assessment, AS1). On the day following the end of training, the sciatica experimental model was performed, and functional disability test data were collected on the third post-operative day, before and after the fi rst treatment (AS2 and ASV3, respectively), after the fi fth day of treatment (AS4), and, fi nally, right after the tenth day of treatment (AS5). The assessments after therapy were performed 30 minutes after the animals recovered from anesthesia.
Assessment of the hind paw withdrawal threshold
Nociception was also assessed through the hind paw withdrawal threshold in response to a mechanical stimulus. The device used in the nociception test was the electronic pressure analgesymeter (Insight ® ). It consists in a transducer arm with a disposable polypropylene pointer (0.1-1.000-g variation), connected with an amplifying box, and measuring the pressure applied to the animal's surface.
The animals were contained manually, and the polypropylene pointer was perpendicularly applied to the nerve compression region, with gradual increase in pressure. As soon as the animal withdrew its right hind paw, the test was interrupted, and withdrawal threshold was recorded. Animal adaptation and training lasted three days. The assessments were always performed in THHP sequence.
Treatment protocol
Treatment was initiated on the third post-operative day, and performed daily, for 10 consecutive days, with 20-minute sessions. A high-voltage device (Neurodyn High Volt, IBRAMED®) was used, with calibration certifi cate valid for the study period.
For applying the high-voltage current specifi cally over the surgical incision, the animals were anesthetized and put in the left lateral decubitus position. Silicone-gum electrodes were positioned over the surgical incision site and the lumbar region of the animals. The area of the active electrode (surgical site) was 1 cm 2 , and that of the passive electrode (lumbar region), 4 cm 2 . The intensity of the current was increased until a muscle contraction was observed, being then reduced by 10% of such value, producing, thus, stimulation only at the sensitive level. The frequency used was 50 Hz.
Analysis of results
The normality of the results was analyzed by use of the Kolmogorov-Smirnov test. Because of their normality, they were expressed by use of descriptive statistics (mean and standard deviation) and analyzed by use of inferential statistics, with repeated measures analysis of variance, Tukey test for intragroup analysis, and non-paired t test for intergroup analysis. For both tests, the signifi cance level adopted was α = 0.05.
RESULTS
Functional disability test
The results were analyzed by comparing the pre-injury assessment with the post-injury assessment, and the postinjury assessment with the subsequent ones. In the GS, a signifi cant increase in nociception was observed between the pre-injury assessment and all subsequent ones. No signifi cant decrease was observed when comparing the assessment prior to the fi rst treatment (AS2) and the subsequent ones ( Figure 1) . The functional disability test showed that the cathodic current produced no signifi cant reduction in nociception. After AS1, no restoration of the values occurred. No signifi cant decrease was observed when comparing AS2 (prior to fi rst therapy) with the following assessments, nor when comparing AS2 with GS. Thus, functionality remained impaired by the increased nociception perceived by the animals due to experimental sciatica (Figure 2) .
No signifi cant variation was observed when comparing GS and GP-at the different assessing times.
DISCUSSION
Considering that the sciatic nerve is the largest nerve of the human body, and is subjected to several types of injury, such as smashing, transection, stretch, and freezing, studies on treatment methods for its injuries are required. Experimental nerve compression models in rats are used due to its similarity
Assessment of the hind paw withdrawal threshold
Assessment of the pressure nociceptive threshold showed a decrease in the hind paw withdrawal threshold for both groupswhen comparing the pre-surgery values (AS1) with pre-treatment values on the third post-operative day (AS2) a signifi cant reduction was observed, a fact that remained after the fi rst therapy (AS3). However, GP- (Figure 3) showed recovery of the initial values in the assessments after the fi fth and tenth therapies, which was not observed for GS (Figure 4) , which continued statistically different as compared with AS1. In addition, in GP-, the AS5 signifi cantly differed from AS2, showing a signifi cant increase in the pressure nociceptive threshold. When GS and GP-were compared in the different assessment times, no signifi cant difference was observed from AS1 to AS4, except for AS5. with the human nerve. 15 It is worth noting that experiments with animals, in addition to generating knowledge, can be reproducible, serving as a valuable source of information for general health -experiments with behavioral measures of neuropathic pain in animals have become increasingly common. 11 In this study, we chose the nerve compression model described by Bennett and Xie, 12 which reproduces the symptoms of sciatica, aiming at assessing the high-voltage current effect, by using the negative pole acting as the active pole (cathodic current), on the evolution of nociception with two different stimuli -one functional and the other by pressure. It is worth emphasizing that nociception is defi ned as "a response to stimuli potentially capable of tissue damage". 16 Thus, the nociception process is aimed at detecting present or potential damage stimuli. 17 According to Sandercock et al., 18 changes in the mechanical nociceptive threshold can demonstrate primary hyperalgesia or its reduction, that is, the increase in the mechanical threshold can show a decrease in hyperalgesia fi ndings.
The nociceptive system exists to concentrate attention on a harmful stimulus, initiate a fl ight response or suppress refl exes to allow for a better organized motor response. The painful stimulus is transmitted from the periphery to the spinal cord and brainstem via small myelinated Aδ fi bers and unmyelinated C fi bers. The fi rst fi bers recruited have high threshold, and the Aδ fi bers transmit the "fi rst pain", perceived as clearly localized and discriminated by its duration, proportional to the application of the painful stimulus. In case of more intense stimuli, the activation of polymodal nociceptors promotes an unpleasant and persistent diffusion of the painful sensation, with longer duration than that of acute pain and with a slight delay in its beginning. That "second pain" is associated with affective characteristics and motivational aspects, and might become prominent during the course of chronic pain. 16 The assessments showed an increase in nociception on the third PO day in both groups, because the values of both the THHP and the pressure necessary for hind paw withdrawal signifi cantly differed from their initial values. According to Bertolini et al., 19 in animals undergoing the nerve compression model, the THHP values are greater than 10 seconds, considering that for animals without increased nociception values close to 10 seconds are expected.
14 This is in accordance with the fi ndings of both groups in this study.
The functional disability test showed that the cathodic current produced no reduction in nociception. That is, the animals continued to limp because of the increase in nociception perceived by the animal due to experimental sciatica, indicating that THHP, although used in other studies to assess the neuropathic pain of the sciatic nerve, 19, 20 has lower sensitivity to small variations, such as the local pressure assessment. Identical result was found when similar methodology of injury was used, but with treatment with anodic high-voltage current. 20 According to Bennett and Xie, 12 the animals showed, after the sciatic nerve compression model, claudication of the paw submitted to surgery. Both humans and animals tend to show dysfunction when using the injured limb. Bennett 21 has reported that the increase in nociception in animals begins from the second PO day onwards, reaching its maximum around the 10 th to 14 th day. Thus, in the present study, nociception and the effect of treatment were assessed from the third PO day onwards, encompassing a period in which, according to the literature, a reduction in the nociceptive threshold occurs. Such alterations were assessed in this study, and directly refl ected on the contact of the paw with the ground observed in the tests before and after surgery.
Both groups showed a decrease in the pressure nociceptive threshold. Such decrease was maintained in the GS, while in the GP-, the values signifi cantly increased after the fi fth and tenth therapies. That indicated that, if no restoration of the values occurred, at least the threshold that was low on the third PO day increased as compared with the values of the eighth and 13 th PO days. That difference between the groups was evident when comparing both in the AS5, because GP-showed a higher nociceptive threshold, indicating, thus, a summation analgesic effect of the current. It is worth noting that the animals were assessed only after recovering from anesthesia, and no analgesia was observed after the fi rst therapy, requiring, thus, summation of therapies. Thus, probable analgesic effects, such as the fl oodgate theory or nerve conduction block, can be ruled out as the cause of the nociception reduction found in this study. 22 Several studies have reported positive effects of the highvoltage current when used with cathodic current stimulation. [23] [24] [25] [26] [27] The present study aimed at assessing the use of that current on the nociception of animals submitted to experimental sciatica, both with functional assessment and local pressure assessment.
According to Davini et al., 13 there is evidence that the highvoltage current can reduce pain. However, further studies are required regarding the use of high-voltage current in cases of sciatica, experimental or clinical, and even regarding analgesia in experimental models.
Stralka et al., 28 using high voltage in individuals with repetitive strain injury, have reported, in addition to edema reduction and strength gain, pain reduction. However, Holcomb et al., 29 using cathodic high-voltage current to inhibit the painful stimulus of neuromuscular electrostimulation, providing, thus, greater intensity of current and, consequently, greater muscle torque, have not observed facilitation of the neuromuscular response. It is worth noting that those authors assessed healthy individuals, who had no pain-inducing disease, because what they wanted was to alter the threshold of pain perception. The occurrence of probable anti-infl ammatory effects of the current, such as an increase in lymphatic fl ow, 30 a reduction in edema, [23] [24] [25] [26] [27] and acceleration in tissue repair, can be infered. 31 Such effects might have aided in removing pain-producing substances and in reducing stasis, favoring a possible analgesic effect of the current, although insuffi cient to improve a functional test, such as THHP.
Regarding the technical limitations of the present study, neither histological nor electrophysiological parameters, which would deepen the responses about the effect mechanisms, were assessed. This is a suggestion for future studies. In addition, electrostimulation with high-voltage current should be compared with other forms already established for sciatica treatment, such as non-steroidal anti-infl ammatory drugs.
CONCLUSION
In conclusion, based on the results obtained and the methodology used, no reduction in nociception, favoring the animal's function, was observed. However, the pressure nociceptive threshold was signifi cantly reduced after fi ve and 10 days of therapy.
